Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. | AHRQ Patient Safety Network

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. | AHRQ Patient Safety Network

• Press Release/Announcement
 
• Published September 2018

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

Silver Spring, MD: US Food and Drug Administration; September 29, 2018.

Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.

Free full text

Related Resources

MEETING/CONFERENCE › FLORIDA MEETING/CONFERENCE

SEIPS Systems Engineering Initiative for Patient Safety.

University of Florida Center for Simulation, Education, and Safety Research, April 1–5, 2019; The River Club, Jacksonville, FL.

MEETING/CONFERENCE › MARYLAND MEETING/CONFERENCE

Patient Safety Certificate Program.

Armstrong Institute for Patient Safety and Quality. October 29-November 2, 2018; Constellation Energy Building, Baltimore, MD.

PATIENT SAFETY PRIMER

Human Factors Engineering

JOURNAL ARTICLE › COMMENTARY

Effective approaches to control non-actionable alarms and alarm fatigue.

Winters BD. J Electrocardiol. 2018 Jul 17; [Epub ahead of print].

JOURNAL ARTICLE › COMMENTARY

Complicated: medical missteps are not inevitable.

Yurkiewicz IR. Health Aff (Millwood). 2018 37:7;1178-1181.

View More